Ibogaine Treatment in Florida

Florida generates a large share of American search interest in ibogaine treatment, which makes the legislative silence worth documenting.

The statute names it

Ibogaine appears at § 893.03(1)(c)18 of the Florida statutes, in the enumeration of hallucinogenic substances within Schedule I. The entry is one word:

18. Ibogaine.

It sits between a methylenedioxy compound and LSD. The paragraph’s preamble covers any material, compound, mixture or preparation containing any quantity of the listed substances, so plant material is caught as a mixture.

Schedule I in Florida means, in the statute’s own terms, a high potential for abuse, no currently accepted medical use in treatment in the United States, and a use under medical supervision that does not meet accepted safety standards.

This is a state listing, independent of the federal one. Ibogaine is named in the text of the federal Controlled Substances Act as well. Why ibogaine is illegal covers how both happened.

The penalty, and a figure that does not apply

Possession of a controlled substance not lawfully obtained is a third-degree felony under § 893.13(6)(a).

There is no research route Florida adds

The statute exempts persons who procure controlled substances in good faith for the purpose of lawful research, teaching or testing, and not for resale.

The operative word is lawful, and for a Schedule I substance that means a federal research registration. Federal law refers Schedule I research applications to the health secretary, who assesses the practitioner’s qualifications and the merits of the protocol. Florida adds no independent pathway.

A general provision allows practitioners to prescribe and administer in the course of professional practice. It does not textually exclude Schedule I, but the exclusion is federal and practical: there is no lawful supply. The reason a Florida physician cannot give you ibogaine is federal, not state.

The legislative silence

This is the finding, and it is a clean one.

The Florida Senate’s full-text search returned about ninety results for ibogaine when we ran it, a figure that drifts as the index is rebuilt. Every single one is an incidental reprint of the Schedule I list inside a bill amending some other part of the schedules: a 2024 bill, a 2025 bill, a 2022 bill, a 2021 bill, an intoxicating-substances bill that became law in 2026 and concerns nitrous oxide and xylazine.

No Florida bill has ever proposed ibogaine research funding, a treatment programme, or rescheduling.

That matters because nine other states have moved. Texas appropriated funds for trials, Kentucky considered a proposal, and Arizona, Mississippi, Oklahoma, Colorado, Indiana, California and Louisiana have all seen ibogaine-specific legislative activity. Florida, with some of the highest demand in the country, has done nothing.

The state health department is equally quiet. Its own site search for ibogaine returns, verbatim, no results found.

Ibogaine in the United States maps the states that have acted, and Texas covers the largest programme.

What this means practically

If you are in Florida and considering this, the honest position is short.

There is no lawful provider in the state and there will not be one under current law. What exists instead is travel, generally to Mexico, and finding treatment sets out what that actually means legally and what it costs you in recourse.

Before any of that, if this is for opioid dependence, the treatments with established mortality benefit are available in Florida today. After treatment explains why leaving them is a decision with its own measured risk.